Bunge Global SA

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 692 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• The single most important feature of this register: Bunge's July 2025 combination with Viterra Limited was paid partly in Bunge stock to Viterra's owners, principally Glencore plc (via its subsidiary Danelo Ltd) and Canada Pension Plan Investment Board (via CPPIB Monroe Canada, Inc. and affiliates), plus a smaller stake to British Columbia Investment Management Corporation (BCI). Glencore (17.08%) and CPP Investments (13.66%) are together larger than Vanguard and BlackRock combined, and both hold board-nomination rights under Shareholder's Agreements executed at closing: each may designate 2 directors while holding at least 10% of Bunge's shares (CPP Investments may designate 1 director while holding between 5% and 10%). Per the joint Schedule 13D filings (Danelo Ltd/Glencore, accession 0001140361-25-025077; CPP Investment Board group, accession 0001104659-25-066494), both Glencore and CPP Investments are subject to, with certain exceptions: (a) a one-year lockup from the 2 Jul 2025 closing date, (b) a prohibition on transfers to Bunge's competitors and to activist investors, (c) non-solicitation and non-compete obligations until the later of 3 years post-closing or 6 months after the holder no longer has a board seat, (d) a standstill preventing acquisition of additional shares above 19.9% of the company until beneficial ownership falls below 7%, and (e) voting commitments in support of Bunge board recommendations. Glencore is labeled holder_type 'strategic'; CPP Investments and BCI are labeled 'sovereign' as Canadian public-sector pension investment managers, per this project's fixed enum.
• Glencore's Bunge position is unusual among foreign corporate holders in this project: it does NOT rely solely on a Schedule 13D. Glencore plc itself (CIK 0001521365) files its own Q2 2026 Form 13F-HR reporting the full 32,806,103 share Bunge position, even though the direct legal holder, its subsidiary Danelo Ltd (CIK 0002058288), files a 13F-NT with no holdings. This project's brief warned that a foreign corporate holder 'may file a 13D or 13G rather than a 13F' and that a missing 13F is not evidence of absence; here the 13F actually exists and was used as the primary, freshest source, cross-checked against the 13D and the DEF 14A.
• Register self-gate, computed from this final file exactly as the chart computes it: 13 register rows, none with rolls_up_into (the directors/officers aggregate has no separately listed members, so it counts at its full stated 2,320,206 shares; no other row is a member of any aggregate). Total: 135,574,671 shares against shares_outstanding 192,119,123 = 70.57% of the company. This is well above the brief's usual 25%-45% band, but is NOT a double count: it is driven by the unusually large, real, independently-filed strategic/sovereign block from the Viterra combination (Glencore + CPP Investments + BCI = 32.9% of the company on their own, all distinct legal persons with distinct CIKs and no shared entities), on top of an otherwise-ordinary index/active institutional base (Capital Group + Vanguard + BlackRock + State Street + Geode + FMR + Invesco + Northern Trust + T. Rowe Price = roughly 37.7%) and a small insider aggregate (1.21%). No holder here rolls up into or duplicates another.
• Implied per-share price cross-check across institutional Q2 2026 13F rows: Glencore approximately $106.74/sh, CPP Investments $106.73/sh, Capital Group $106.75/sh, Vanguard family $106.74/sh, BlackRock $106.72/sh, State Street $106.75/sh, Geode $106.31/sh, FMR $106.72/sh, Invesco $106.74/sh, Northern Trust $106.73/sh, BCI $106.74/sh, T. Rowe Price $106.75/sh (after correcting for its thousands-scaled value field). All twelve cluster tightly at $106.3 to $106.8/sh, confirming no unit, share-class, or thousands-scaling error survived on any row. This 30 Jun 2026 implied price is below the 19 Aug 2026 close of $114.00 used for market_cap_usd, a genuine 6-7 week price move rather than an inconsistency.
• Bunge's FY2025 10-K (Note 11) discloses ONLY a combined, summarized balance sheet and income statement for ALL equity-method investees together: Total assets $8,096 million (2025) / $5,516 million (2024); Total liabilities $5,150 million (2025) / $3,881 million (2024); Net sales $13,545 million (2025); Net income $33 million (2025). The Q2 2026 10-Q separately discloses a combined balance-sheet line 'Investments in affiliates' of $1,307 million (30 Jun 2026) versus $1,495 million (31 Dec 2025). Per this project's rule against assigning a combined balance to any one investee, NONE of these figures is used to size any individual holding above; every JV holding's value_usd is null.
• BP Bunge Bioenergia, a 50%-owned sugar and bioenergy joint venture with BP, was FULLY SOLD to BP on 1 October 2024 for net consideration of approximately $828 million (a $195 million pretax gain was recorded). This is a completed, dated exit and is recorded here as a note with NO row, per this project's convention.
• Terminal XXXIX De Santos S.A. (T-39): Bunge agreed in May 2024 to acquire a 25% interest, but the seller formally TERMINATED the share purchase agreement in June 2025 before closing. No holding was ever completed; excluded entirely, no row.
• Terminal de Granéis de Santa Catarina (TGSC): previously a variable interest entity that Bunge held a call option over (not an equity-method affiliate), consolidated as primary beneficiary. In March 2025 Bunge exercised the option and acquired ALL shares of TGSC for approximately $85 million, making it a wholly owned, fully consolidated subsidiary. Not a holding as of the FY2025 10-K or Q2 2026 10-Q; excluded as effectively wholly owned.
• Bunge Loders Croklaan (Loders), a specialty tropical-oils joint venture with IOI Corporation Berhad, runs the OTHER way from the JV holdings above: Bunge owns 80% and CONSOLIDATES Loders, with IOI holding a 20% noncontrolling interest (the 10-K explicitly discusses 'EBIT attributable to noncontrolling interests... in our Loders joint venture'). Per this project's guidance not to turn an NCI into a holding, Loders is excluded from the holdings list entirely.
• Exhibit 21 (subsidiaries list) of the FY2025 10-K was checked and found to be a bare name list with a single footnote stating it covers entities '50% ownership or greater, consolidated'; it carries no per-entity ownership-percentage column and does not disaggregate the Terminal 6 S.A./Terminal 6 Industrial S.A. percentages. This is a genuine negative, consistent with this project's guidance that Exhibit 21's format varies by registrant and sometimes gives nothing.
• The FY2025 10-K's itemized equity-method table is introduced as covering only 'Certain significant equity method investments', implying smaller, unnamed equity-method investees may exist beyond the 10 listed here; these are not separately identified or sized in any filing checked.
• Only the top institutional/strategic/sovereign holders plus the insider aggregate are included here (13 rows); this project's own Q1 2026 register snapshot (data/registers/BG.json) lists 40 holders in total, and smaller managers below Northern Trust/BCI in size (e.g. FIL Ltd/Fidelity International, Dimensional Fund Advisors, Charles Schwab Investment Management, Morgan Stanley, Deutsche Bank, BNY Mellon, Amundi, UBS, and various hedge funds) were not individually re-verified for Q2 2026 within this task's time budget.